RINI MATHEWS: Open Payments
NPI 1972113363 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 50 payments from 10 companies in 2025. Trend: 2023 $476 · 2024 $1,191 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $440 |
| Bayer Healthcare Pharmaceuticals Inc. | 19 | $165 |
| Amgen Inc. | 9 | $142 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $138 |
| Novo Nordisk Inc | 3 | $66 |
| Astellas Pharma US Inc | 1 | $28 |
| Exact Sciences Corporation | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: AIRSUPRA, Kerendia, ISTURISA, OTEZLA, BREZTRI, FARXIGA, Wegovy, Veozah.
Industry payments across NV — which companies pay providers there.
